Search Results

There are 2045 results for: content related to: Clinical and virologic outcomes in patients with oseltamivir-resistant seasonal influenza A (H1N1) infections: results from a clinical trial

  1. You have free access to this content
    Cochrane Review: Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)

    Evidence-Based Child Health: A Cochrane Review Journal

    Volume 7, Issue 5, September 2012, Pages: 1719–1790, Kay Wang, Matthew Shun-Shin, Peter Gill, Rafael Perera and Anthony Harnden

    Version of Record online : 6 SEP 2012, DOI: 10.1002/ebch.1871

  2. Population Pharmacokinetics of Oseltamivir When Coadministered With Probenecid

    The Journal of Clinical Pharmacology

    Volume 48, Issue 8, August 2008, Pages: 935–947, Dr Craig R. Rayner, Dr Pascal Chanu, Dr Ronald Gieschke, Dr Lauren M. Boak and Dr E. Niclas Jonsson

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008320317

  3. You have free access to this content
    Oseltamivir Blocks Human Neuronal Nicotinic Acetylcholine Receptor-Mediated Currents

    Basic & Clinical Pharmacology & Toxicology

    Volume 116, Issue 2, February 2015, Pages: 87–95, Katsuhiko Muraki, Noriyuki Hatano, Hiroka Suzuki, Yukiko Muraki, Yui Iwajima, Yasuhiro Maeda and Hideki Ono

    Version of Record online : 31 JUL 2014, DOI: 10.1111/bcpt.12290

  4. Similarity in Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Japanese and Caucasian Subjects

    The Journal of Clinical Pharmacology

    Volume 47, Issue 6, June 2007, Pages: 689–696, Jerome J. Schentag, George Hill, Tom Chu and Craig R. Rayner

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007299761

  5. Impact of time to treatment of oseltamivir on influenza hospitalization cost among Korean children

    Pediatrics International

    Volume 57, Issue 3, June 2015, Pages: 393–400, Jacqueline K Lim, Paul E Kilgore, Allison E Aiello, Betsy Foxman, G William Letson, Gi-Young Jang, Eunhee Chung, Young-Hwan Song and Yun-Kyung Kim

    Version of Record online : 22 JAN 2015, DOI: 10.1111/ped.12526

  6. You have full text access to this Open Access content
    Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance

    Influenza and Other Respiratory Viruses

    Volume 7, Issue s1, January 2013, Pages: 25–36, Jennifer L. McKimm-Breschkin

    Version of Record online : 28 DEC 2012, DOI: 10.1111/irv.12047

  7. Pharmacokinetic Properties ofAnti-Influenza Neuraminidase Inhibitors

    The Journal of Clinical Pharmacology

    Volume 53, Issue 2, February 2013, Pages: 119–139, Kalayanee Chairat, Joel Tarning, Nicholas J. White and Niklas Lindegardh

    Version of Record online : 24 JAN 2013, DOI: 10.1177/0091270012440280

  8. Safety profile of oseltamivir during the 2009 influenza pandemic

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 532–543, Barbara Donner, Silvia Bader-Weder, Roman Schwarz, Michael M. Peng, James Robert Smith and Viswanathan Niranjan

    Version of Record online : 29 MAR 2011, DOI: 10.1002/pds.2136

  9. You have free access to this content
    Effect of milk on the pharmacokinetics of oseltamivir in healthy volunteers

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 9, September 2011, Pages: 3854–3861, Kaori Morimoto, Kozue Kishimura, Takaaki Nagami, Nao Kodama, Yoichiro Ogama, Midori Yokoyama, Shinya Toda, Takeshi Chiyoda, Rieko Shimada, Akihiro Inano, Takashi Kano, Ikumi Tamai and Takuo Ogihara

    Version of Record online : 23 MAY 2011, DOI: 10.1002/jps.22627

  10. Pharmacokinetics and Safety of Coadministered Oseltamivir and Rimantadine in Healthy Volunteers: An Open-Label, Multiple-Dose, Randomized, Crossover Study

    The Journal of Clinical Pharmacology

    Volume 52, Issue 8, August 2012, Pages: 1255–1264, Georgina Cirrincione-Dall, Barbara J. Brennan, Rosa M. Ballester-Sanchis, Mercidita T. Navarro and Brian E. Davies

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011412960

  11. You have free access to this content
    Effect of oseltamivir treatment on anticoagulation: a cross-over study in warfarinized patients

    British Journal of Clinical Pharmacology

    Volume 70, Issue 6, December 2010, Pages: 834–843, Brian E. Davies, Pau Aceves Baldó, Sian Lennon-Chrimes and Mike Brewster

    Version of Record online : 11 NOV 2010, DOI: 10.1111/j.1365-2125.2010.03780.x

  12. Association of Oseltamivir Activation with Gender and Carboxylesterase 1 Genetic Polymorphisms

    Basic & Clinical Pharmacology & Toxicology

    Accepted manuscript online: 26 MAY 2016, Jian Shi, Xinwen Wang, Rachel F. Eyler, Yan Liang, Li Liu, Bruce A. Mueller and Hao-Jie Zhu

    DOI: 10.1111/bcpt.12625

  13. Antivirals: Targets and use

    Textbook of Influenza, 2nd Edition

    Michael G. Ison, Alan Hay, Pages: 392–418, 2013

    Published Online : 16 AUG 2013, DOI: 10.1002/9781118636817.ch25

  14. Carboxylesterase 1 Polymorphism Impairs Oseltamivir Bioactivation in Humans

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 1, July 2012, Pages: 68–71, E K Tarkiainen, J T Backman, M Neuvonen, P J Neuvonen, M Schwab and M Niemi

    Version of Record online : 16 MAY 2012, DOI: 10.1038/clpt.2012.13

  15. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009–2011

    Journal of Medical Virology

    Volume 85, Issue 3, March 2013, Pages: 379–387, Ji-Rong Yang, Yuan-Pin Huang, Feng-Yee Chang, Li-Ching Hsu, Hsiang-Yi Huang, Yi-Tsan Pan, Yu-Cheng Lin, Ho-Sheng Wu and Ming-Tsan Liu

    Version of Record online : 21 DEC 2012, DOI: 10.1002/jmv.23482

  16. Absence of Pharmacokinetic Interaction Between Intravenous Peramivir and Oral Oseltamivir or Rimantadine in Humans

    The Journal of Clinical Pharmacology

    Volume 52, Issue 9, September 2012, Pages: 1410–1419, George Atiee, Kenneth Lasseter, Sharon Baughman, Amy McCullough, Phil Collis, Alan Hollister and Jaime Hernandez

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011414574

  17. The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64–0796/GS4104) in Healthy Adult and Elderly Volunteers

    The Journal of Clinical Pharmacology

    Volume 40, Issue 8, August 2000, Pages: 836–843, Dr. Joseph W. Massarella, Dr. George Z. He, Dr. Albert Dorr, Dr. Keith Nieforth, Dr. Penelope Ward and Mr. Andy Brown

    Version of Record online : 8 MAR 2013, DOI: 10.1177/00912700022009567

  18. You have full text access to this Open Access content
    Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses

    Influenza and Other Respiratory Viruses

    Volume 7, Issue s1, January 2013, Pages: 50–57, Elena A. Govorkova

    Version of Record online : 28 DEC 2012, DOI: 10.1111/irv.12044

  19. Health outcomes among patients receiving oseltamivir

    Pharmacoepidemiology and Drug Safety

    Volume 13, Issue 4, April 2004, Pages: 227–237, Cheryl Enger, Beth L. Nordstrom, Bharat Thakrar, Susan Sacks and Kenneth J. Rothman

    Version of Record online : 6 MAY 2003, DOI: 10.1002/pds.845

  20. Identification of new oral dosing regimens for the neuraminidase inhibitor oseltamivir in patients with moderate and severe renal impairment

    Clinical Pharmacology in Drug Development

    Volume 4, Issue 5, September/October 2015, Pages: 326–336, Mohamed A. Kamal, Barbara J. Brennan, Vishak Subramoney, Yi Ting (Kayla) Lien, Peter N. Morcos, Nicolas Frey and Craig R. Rayner

    Version of Record online : 2 JUL 2015, DOI: 10.1002/cpdd.203